JESSICA WILLIAMSEN: Open Payments
NPI 1679942353 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 17 payments from 11 companies in 2025. Trend: 2023 $488 · 2024 $342 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| Astellas Pharma US Inc | 2 | $48 |
| Novo Nordisk Inc | 2 | $30 |
| ABBVIE INC. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: LEQVIO, Xtandi, VYNDAMAX, Veozah, QULIPTA, TZIELD, JARDIANCE, VYNDAQEL.
Industry payments across NE — which companies pay providers there.
